Viskase 

$5.10
10
+$0.70+15.91% 14:46 Today

Statistics

Day High
4.4
Day Low
4.4
52W High
8.55
52W Low
0.02
Volume
600
Avg. Volume
1,514
Mkt Cap
73.09M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Oct 19
$12.00
Mar 19
$6.00
Sep 17
$15.00
Dec 16
$15.00
Dec 15
$25.00
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

9NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.01
-0.01
-0
0
Expected EPS
0
Actual EPS
-0.01

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-5.53MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ENZN. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap162.98B
Gilead Sciences is a biopharmaceutical company that competes in the development of drugs for infectious diseases, a market Enzon Pharmaceuticals also targets.
AMGEN
AMGN
Mkt Cap201.93B
Amgen is a biotech firm focusing on novel therapeutics, including treatments for serious illnesses, overlapping with Enzon's therapeutic areas.
Bristol-Myers Squibb
BMY
Mkt Cap118.71B
Bristol-Myers Squibb is involved in discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases, similar to Enzon's mission.
Pfizer
PFE
Mkt Cap138.61B
Pfizer is a global pharmaceutical company with a broad range of drugs and vaccines, competing across several of the same therapeutic areas as Enzon.
Merck
MRK
Mkt Cap319.99B
Merck operates in the pharmaceutical sector, focusing on drugs for conditions that Enzon Pharmaceuticals also aims to treat, making them direct competitors.
Abbvie
ABBV
Mkt Cap461.26B
AbbVie is a research-based biopharmaceutical company with a significant focus on developing treatments for serious diseases, competing with Enzon in drug development.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.59B
Regeneron Pharmaceuticals specializes in the invention of medicines for serious medical conditions, directly competing with Enzon in the biopharmaceutical field.
Biogen
BIIB
Mkt Cap31.91B
Biogen is a biotechnology company that develops therapies for neurological and neurodegenerative diseases, competing with Enzon in the biopharmaceutical market.
Vertex Pharmaceuticals
VRTX
Mkt Cap134.02B
Vertex Pharmaceuticals is known for creating new possibilities in medicine to cure diseases and improve people's lives, competing with Enzon in drug innovation.
Novartis
NVS
Mkt Cap305.1B
Novartis is a global healthcare company that provides solutions to address the evolving needs of patients worldwide, including areas where Enzon operates.

About

Viskase Companies, Inc., together with its subsidiaries, produces and sells non-edible cellulosic, fibrous, and plastic casings for preparing and packaging processed meat products and services in North America, South America, Europe, Asia, and internationally. The company offers NOJAX cellulose casings for use in the automated production of hot dogs, dry mini salamis, and cooked and coarse ground sausages; and large cellulose casings to give cylindrical or oval shape to the processed meats that are used in bologna, mortadella, deli ham, bierwurst, and dry sausages. It also provides VISDRY casings for dried or smoked sausages; VISFLEX casings for cheese and processed meat applications; VISMAX casings for molded, and formed processed meat and poultry applications; VISLON for meat, poultry, and cheese applications; VISMOKE casings for cooked and smoked meat products, semi-dry sausages, and spreadable dry sausages; VISCOAT casings for a range of applications, including turkey, ham, and roast beef products; and POLYJAX casings for the production of hot dog, sausage, chorizo products, and meat snack sticks. In addition, the company provides fibrous casings for use in a range of applications, including pepperoni, salami, boneless hams, luncheon meats, and other deli-style processed meats, as well as for processed and smoked cheeses; color transfer casings for a range of natural and synthetic shades; flavor transfer casings for taste profiles; smoke transfer casings for processed meat or cheese products; and spice transfer casings for processing facility. Additionally, it offers textile spice transfer casings for transfer of the spice to the food; Ve-Net products; and MEMBRA-CEL, a dialysis membranes made from regenerated cellulose. The company was founded in 1925 and is based in Lombard, Illinois. Viskase Companies, Inc. is a subsidiary of Icahn Enterprises L.P.
Show more...
CEO
Mr. Maurice J. Ryan
Employees
1582
Country
United States
ISIN
US2939048011

Listings

0 Comments

Share your thoughts

FAQ

What is Viskase stock price today?
The current price of ENZN is $5.10 USD — it has increased by +15.91% in the past 24 hours. Watch Viskase stock price performance more closely on the chart.
What is Viskase stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Viskase stocks are traded under the ticker ENZN.
Is Viskase stock price growing?
ENZN stock has risen by +5.85% compared to the previous week, the month change is a -7.27% fall, over the last year Viskase has showed a -49% decrease.
What is Viskase market cap?
Today Viskase has the market capitalization of 73.09M
What were Viskase earnings last quarter?
ENZN earnings for the last quarter are -0.01 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Viskase revenue for the last year?
Viskase revenue for the last year amounts to 0 USD.
What is Viskase net income for the last year?
ENZN net income for the last year is -5.53M USD.
Does Viskase pay dividends?
Yes, ENZN dividends are paid annual. The last dividend per share was 12 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Viskase have?
As of July 09, 2026, the company has 1,582 employees.
In which sector is Viskase located?
Viskase operates in the Health & Wellness sector.
When did Viskase complete a stock split?
The last stock split for Viskase was on March 25, 2026 with a ratio of 1:100.
Where is Viskase headquartered?
Viskase is headquartered in Lombard, United States.